Table 2 Association analysis of chronic migraine with sociodemographic, clinical, and analgesic overuse variables
Variable (reference category) | Chronic migraine | |
|---|---|---|
Crude OR (95% CI)1 | Adjusted OR (95% CI)1 | |
Age | 16.4 (0.01–16.4 ) | 4,60 (0.01–22.9) |
Sex (female) | 0,006 (0.01 − 0.006)* | 0,01 (0.001–0.01)* |
Low socioeconomic status (high) | 2,93 (0.01–2.93) | 2,22 (0.01-6) |
Middle socioeconomic status (high) | 0,135 (0.01–0.135)* | 0,16 (0.001–0.01)* |
Duration of migraine evolution | 0,56 (0.01–0.56)* | 0,60 (0.01–0.1)* |
Migraine severity (mild-moderate) | 2,6 (0.01–2.6) | 2,05 (0.01–5.3) |
History of depression | 11043,4 (0.01–11043) | 6,00 (0.01–11061) |
History of anxiety | 1721,13 (0.01–1721) | 5,99 (0.01–1735) |
Sleep disorders | 3,11 (0.01–3.11) | 2,30 (0.01–6.4) |
Use of medications that alter cognition | 1,28 (0.01–1.28) | 1,22 (0.01–1.9) |
MMSE | 1,3 (0.01–1.3) | 1,24 (0.01–1.9) |
TMT A low | 8,54 (0.01–8.54) | 3,79 (0.01-14) |
TMT A high | 1,9 (0.01–1.9) | 1,65 (0.01–3.7) |
TMT B low | 3,2 (0.01–3.2) | 2,34 (0.01–6.5) |
TMT B high | 2,7 (0.01–2.7) | 2,10 (0.01–5.6) |
Rey figure: Normal | 4,5 (0.01–4.5) | 2,84 (0.01–8.7) |
Rey figure: high | 7,11 (0.01–7.11) | 3,52 (0.01–12.2) |